{
  "DOI": "10.1007/s10689-012-9539-1",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-012-9539-1",
  "alternative-id": [
    "9539"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "This",
      "given": "Pascale",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "de la Rochefordière",
      "given": "Anne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Savignoni",
      "given": "Alexia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Falcou",
      "given": "Marie Christine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tardivon",
      "given": "Anne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Thibault",
      "given": "Fabienne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Alran",
      "given": "Séverine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Fourchotte",
      "given": "Virgine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Fitoussi",
      "given": "Alfred",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Couturaud",
      "given": "Benoit",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dolbeault",
      "given": "Sylvie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Salmon",
      "given": "Remy J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sigal-Zafrani",
      "given": "Brigitte",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Asselain",
      "given": "Bernard",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Stoppa-Lyonnet",
      "given": "Dominique",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2012,
        6,
        18
      ]
    ],
    "date-time": "2012-06-18T15:42:24Z",
    "timestamp": 1340034144000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        6,
        23
      ]
    ],
    "date-time": "2023-06-23T15:17:29Z",
    "timestamp": 1687533449000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        12
      ]
    ],
    "date-time": "2024-02-12T16:01:45Z",
    "timestamp": 1707753705690
  },
  "is-referenced-by-count": 11,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2012,
        6,
        19
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2012,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2012,
            6,
            19
          ]
        ],
        "date-time": "2012-06-19T00:00:00Z",
        "timestamp": 1340064000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-012-9539-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-012-9539-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-012-9539-1",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "473-482",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2012,
        6,
        19
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2012,
        6,
        19
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2012,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "journal-title": "Am J Hum Genet",
      "key": "9539_CR1",
      "unstructured": "Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2006.09.1066",
      "author": "S Chen",
      "doi-asserted-by": "crossref",
      "first-page": "1329",
      "journal-title": "J Clin Oncol",
      "key": "9539_CR2",
      "unstructured": "Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329–1333",
      "volume": "25",
      "year": "2007"
    },
    {
      "key": "9539_CR3",
      "unstructured": "Belot A, Velten M, Grosclaude P, Bossard N, Launoy G, Remontet L et al. 2008 Estimation nationale de l’incidence et de la mortalité par cancer en France entre 1980 et 2005. St Maurice (Fra): Institut de Veille sanitaire, décembre 2008. Disponible sur www.invs.sante.fr"
    },
    {
      "DOI": "10.1023/A:1008389021382",
      "author": "F Eisinger",
      "doi-asserted-by": "crossref",
      "first-page": "939",
      "journal-title": "Ann Oncol",
      "key": "9539_CR4",
      "unstructured": "Eisinger F, Alby N, Bremond A, Dauplat J, Espie M, Janiaud P et al (1998) Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee. Ann Oncol 9:939–950",
      "volume": "9",
      "year": "1998"
    },
    {
      "author": "F Eisinger",
      "first-page": "219",
      "journal-title": "Bull Cancer",
      "key": "9539_CR5",
      "unstructured": "Eisinger F, Bressac B, Castaigne D, Cottu P, Lansac J, Lefranc J et al (2004) Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l’ovaire (mise à jour 2004). Bull Cancer 91:219–237",
      "volume": "91",
      "year": "2004"
    },
    {
      "DOI": "10.1002/cncr.23903",
      "author": "GF Schwartz",
      "doi-asserted-by": "crossref",
      "first-page": "2627",
      "journal-title": "Cancer",
      "key": "9539_CR6",
      "unstructured": "Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Is Fentiman, Me Robson et al (2008) Proceedings of the international consensus conference on breast cancer risk, genetics, and risk management, April, 2007. Cancer 113:2627–2637",
      "volume": "113",
      "year": "2008"
    },
    {
      "DOI": "10.3322/canjclin.57.2.75",
      "author": "D Saslow",
      "doi-asserted-by": "crossref",
      "first-page": "75",
      "journal-title": "CA Cancer J Clin",
      "key": "9539_CR7",
      "unstructured": "Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75–89",
      "volume": "57",
      "year": "2007"
    },
    {
      "DOI": "10.1200/JCO.2009.27.0835",
      "author": "E Warner",
      "doi-asserted-by": "crossref",
      "first-page": "1664",
      "journal-title": "J Clin Oncol",
      "key": "9539_CR8",
      "unstructured": "Warner E, Hill K, Causer P, Plewes D, Jong R, Yaffe M et al (2011) Prospective Study of Breast Cancer Incidence in Women With a BRCA1 or BRCA2 Mutation Under Surveillance With and Without Magnetic Resonance Imaging. J Clin Oncol 29:1664–1669",
      "volume": "29",
      "year": "2011"
    },
    {
      "DOI": "10.1002/ijc.22817",
      "author": "MJ Bermejo-Perez",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "journal-title": "Int J Cancer",
      "key": "9539_CR9",
      "unstructured": "Bermejo-Perez MJ, Marquez-Calderon S, Llanos-Mendez A (2007) Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: a systematic review. Int J Cancer 121:225–231",
      "volume": "121",
      "year": "2007"
    },
    {
      "DOI": "10.1001/jama.2010.1237",
      "author": "SM Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "967",
      "journal-title": "JAMA",
      "key": "9539_CR10",
      "unstructured": "Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304:967–975",
      "volume": "304",
      "year": "2010"
    },
    {
      "DOI": "10.1001/jama.284.3.319",
      "author": "MH Frost",
      "doi-asserted-by": "crossref",
      "first-page": "319",
      "journal-title": "JAMA",
      "key": "9539_CR11",
      "unstructured": "Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284:319–324",
      "volume": "284",
      "year": "2000"
    },
    {
      "DOI": "10.1200/JCO.2007.13.9568",
      "author": "Y Brandberg",
      "doi-asserted-by": "crossref",
      "first-page": "3943",
      "journal-title": "J Clin Oncol",
      "key": "9539_CR12",
      "unstructured": "Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A et al (2008) Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 26:3943–3949",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.breast.2010.05.003",
      "author": "J Gahm",
      "doi-asserted-by": "crossref",
      "first-page": "462",
      "journal-title": "Breast",
      "key": "9539_CR13",
      "unstructured": "Gahm J, Wickman M, Brandberg Y (2010) Bilateral prophylactic mastectomy in women with inherited risk of breast cancer–prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast 19:462–469",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2005.11.027",
      "author": "J Cuzick",
      "doi-asserted-by": "crossref",
      "first-page": "1636",
      "journal-title": "J Clin Oncol",
      "key": "9539_CR14",
      "unstructured": "Cuzick J (2005) Aromatase inhibitors for breast cancer prevention. J Clin Oncol 23:1636–1643",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJMoa1103507",
      "author": "PE Goss",
      "doi-asserted-by": "crossref",
      "first-page": "2381",
      "journal-title": "N Engl J Med",
      "key": "9539_CR15",
      "unstructured": "Goss PE, Ingle JN, Ales-Martinez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J et al (2011) Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364:2381–2391",
      "volume": "364",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10689-011-9484-4",
      "author": "P Pujol",
      "doi-asserted-by": "crossref",
      "first-page": "77",
      "journal-title": "Fam Cancer",
      "key": "9539_CR16",
      "unstructured": "Pujol P, Lasset C, Berthet P, Dugast C, Delaloge S, Fricker JP et al (2012) Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial. Fam Cancer 11:77–84",
      "volume": "11",
      "year": "2012"
    },
    {
      "DOI": "10.1111/j.1471-0528.2007.01499.x",
      "author": "ER Woodward",
      "doi-asserted-by": "crossref",
      "first-page": "1500",
      "journal-title": "BJOG",
      "key": "9539_CR17",
      "unstructured": "Woodward ER, Sleightholme HV, Considine AM, Williamson S, Mchugo JM, Cruger DG (2007) Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective. BJOG 114:1500–1509",
      "volume": "114",
      "year": "2007"
    },
    {
      "key": "9539_CR18",
      "unstructured": "Inca (2009) Principales recommandations de prise en charge des personnes porteuses d’une mutation de BRCA 1 ou BRCA2 In: http://wwwe-cancerfr/soins/prise-en-charge-specifiques/oncogénétique"
    },
    {
      "DOI": "10.1093/jnci/djn442",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "80",
      "journal-title": "J Natl Cancer Inst",
      "key": "9539_CR19",
      "unstructured": "Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101:80–87",
      "volume": "101",
      "year": "2009"
    },
    {
      "author": "D Stoppa-Lyonnet",
      "first-page": "1021",
      "journal-title": "Am J Hum Genet",
      "key": "9539_CR20",
      "unstructured": "Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pages S, Ithier G, Ligot L et al (1997) BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet 60:1021–1030",
      "volume": "60",
      "year": "1997"
    },
    {
      "DOI": "10.1038/sj.onc.1205685",
      "author": "S Gad",
      "doi-asserted-by": "crossref",
      "first-page": "6841",
      "journal-title": "Oncogene",
      "key": "9539_CR21",
      "unstructured": "Gad S, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, Pujol P et al (2002) Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21:6841–6847",
      "volume": "21",
      "year": "2002"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-04-2467",
      "author": "I Tournier",
      "doi-asserted-by": "crossref",
      "first-page": "8143",
      "journal-title": "Cancer Res",
      "key": "9539_CR22",
      "unstructured": "Tournier I, Bb Paillerets, Sobol H, Stoppa-Lyonnet D, Lidereau R, Barrois M et al (2004) Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 64:8143–8147",
      "volume": "64",
      "year": "2004"
    },
    {
      "DOI": "10.1002/elps.200700010",
      "author": "J Weber",
      "doi-asserted-by": "crossref",
      "first-page": "4282",
      "journal-title": "Electrophoresis",
      "key": "9539_CR23",
      "unstructured": "Weber J, Miserere S, Champ J, Looten R, Stoppa-Lyonnet D, Viovy JL et al (2007) High-throughput simultaneous detection of point mutations and large-scale rearrangements by CE. Electrophoresis 28:4282–4288",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1002/humu.21414",
      "author": "V Caux-Moncoutier",
      "doi-asserted-by": "crossref",
      "first-page": "325",
      "journal-title": "Hum Mutat",
      "key": "9539_CR24",
      "unstructured": "Caux-Moncoutier V, Castera L, Tirapo C, Michaux D, Remon MA, Lauge A et al (2010) EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients. Hum Mutat 32:325–334",
      "volume": "32",
      "year": "2010"
    },
    {
      "key": "9539_CR25",
      "unstructured": "R Development Core Team (2010) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/"
    },
    {
      "DOI": "10.1200/JCO.2002.02.026",
      "author": "SE Singletary",
      "doi-asserted-by": "crossref",
      "first-page": "3628",
      "journal-title": "J Clin Oncol",
      "key": "9539_CR26",
      "unstructured": "Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI et al (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628–3636",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1158/1055-9965.1989.13.12",
      "author": "S Wainberg",
      "doi-asserted-by": "crossref",
      "first-page": "1989",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9539_CR27",
      "unstructured": "Wainberg S, Husted J (2004) Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiol Biomarkers Prev 13:1989–1995",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-09-0171",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "2318",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9539_CR28",
      "unstructured": "Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD et al (2009) Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Cancer Epidemiol Biomarkers Prev 18:2318–2324",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.20.5.1260",
      "author": "L Scheuer",
      "doi-asserted-by": "crossref",
      "first-page": "1260",
      "journal-title": "J Clin Oncol",
      "key": "9539_CR29",
      "unstructured": "Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260–1268",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1023/A:1015269620265",
      "author": "LN Lodder",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9539_CR30",
      "unstructured": "Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Seynaeve C et al (2002) One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 73:97–112",
      "volume": "73",
      "year": "2002"
    },
    {
      "DOI": "10.1002/1097-0142(20010815)92:4\u003c959::AID-CNCR1406\u003e3.0.CO;2-V",
      "author": "CM Julian-Reynier",
      "doi-asserted-by": "crossref",
      "first-page": "959",
      "journal-title": "Cancer",
      "key": "9539_CR31",
      "unstructured": "Julian-Reynier CM, Bouchard LJ, Evans DG, Eisinger FA, Foulkes WD, Kerr B et al (2001) Women’s attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women. Cancer 92:959–968",
      "volume": "92",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0140-6736(05)70394-9",
      "author": "C Julian-Reynier",
      "doi-asserted-by": "crossref",
      "first-page": "1687",
      "journal-title": "Lancet",
      "key": "9539_CR32",
      "unstructured": "Julian-Reynier C, Eisinger F, Evans G, Foulkes W, Sobol H (2000) Variation in prophylactic surgery decisions. Lancet 356:1687",
      "volume": "356",
      "year": "2000"
    },
    {
      "DOI": "10.1097/GIM.0b013e318163487d",
      "author": "AR Bradbury",
      "doi-asserted-by": "crossref",
      "first-page": "161",
      "journal-title": "Genet Med",
      "key": "9539_CR33",
      "unstructured": "Bradbury AR, Ibe CN, Dignam JJ, Cummings SA, Verp M, White MA et al (2008) Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers. Genet Med 10:161–166",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2004.00.8151",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "7804",
      "journal-title": "J Clin Oncol",
      "key": "9539_CR34",
      "unstructured": "Rebbeck TR, Friebel T, Wagner T, Lynch HT, Garber JE, Daly MB et al (2005) Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 23:7804–7810",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1186/1897-4287-3-4-181",
      "author": "P This",
      "doi-asserted-by": "crossref",
      "first-page": "181",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "9539_CR35",
      "unstructured": "This P, Salmon RJ, Dolbeault S, De La Rochefordiere A, Sigal-Zafrani B, Stoppa-Lyonnet D (2005) Hormone replacement therapy after prophylactic adnexectomy. Hered Cancer Clin Pract 3:181–182",
      "volume": "3",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJM200107193450301",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "crossref",
      "first-page": "159",
      "journal-title": "N Engl J Med",
      "key": "9539_CR36",
      "unstructured": "Meijers-Heijboer H, Van Geel B, Van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159–164",
      "volume": "345",
      "year": "2001"
    },
    {
      "DOI": "10.1093/annonc/mdq660",
      "author": "RL Milne",
      "doi-asserted-by": "crossref",
      "first-page": "i11",
      "issue": "Suppl 1",
      "journal-title": "Ann Oncol",
      "key": "9539_CR37",
      "unstructured": "Milne RL, Antoniou AC (2011) Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers. Ann Oncol 22(Suppl 1):i11–i17",
      "volume": "22",
      "year": "2011"
    },
    {
      "DOI": "10.1001/jama.296.2.185",
      "author": "A Finch",
      "doi-asserted-by": "crossref",
      "first-page": "185",
      "journal-title": "JAMA",
      "key": "9539_CR38",
      "unstructured": "Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B et al (2006) Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 296:185–192",
      "volume": "296",
      "year": "2006"
    },
    {
      "DOI": "10.1002/cncr.22603",
      "author": "F Laki",
      "doi-asserted-by": "crossref",
      "first-page": "1784",
      "journal-title": "Cancer",
      "key": "9539_CR39",
      "unstructured": "Laki F, Kirova YM, This P, Plancher C, Asselain B, Sastre X et al (2007) Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation. Cancer 109:1784–1790",
      "volume": "109",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJMcp071286",
      "author": "M Robson",
      "doi-asserted-by": "crossref",
      "first-page": "154",
      "journal-title": "N Engl J Med",
      "key": "9539_CR40",
      "unstructured": "Robson M, Offit K (2007) Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 357:154–162",
      "volume": "357",
      "year": "2007"
    },
    {
      "DOI": "10.1200/JCO.2009.22.7991",
      "author": "AW Kurian",
      "doi-asserted-by": "crossref",
      "first-page": "222",
      "journal-title": "J Clin Oncol",
      "key": "9539_CR41",
      "unstructured": "Kurian AW, Sigal BM, Plevritis SK (2010) Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol 28:222–231",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10549-010-1043-4",
      "author": "VR Grann",
      "doi-asserted-by": "crossref",
      "first-page": "837",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9539_CR42",
      "unstructured": "Grann VR, Patel PR, Jacobson JS, Warner E, Df Heitjan, Ashby-Thompson M et al (2011) Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Res Treat 125:837–847",
      "volume": "125",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nrclinonc.2010.175",
      "author": "AH Trainer",
      "doi-asserted-by": "crossref",
      "first-page": "708",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "9539_CR43",
      "unstructured": "Trainer AH, Lewis CR, Tucker K, Meiser B, Friedlander M, Ward RL (2010) The role of BRCA mutation testing in determining breast cancer therapy. Nat Rev Clin Oncol 7:708–717",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1399-0004.2007.00859.x",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "208",
      "journal-title": "Clin Genet",
      "key": "9539_CR44",
      "unstructured": "Metcalfe KA, Poll A, O’connor A, Gershman S, Armel S, Finch A et al (2007) Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. Clin Genet 72:208–217",
      "volume": "72",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s10689-009-9311-3",
      "author": "KM Landsbergen",
      "doi-asserted-by": "crossref",
      "first-page": "213",
      "journal-title": "Fam Cancer",
      "key": "9539_CR45",
      "unstructured": "Landsbergen KM, Prins JB, Kamm YJ, Brunner HG, Hoogerbrugge N (2010) Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2 years. Fam Cancer 9:213–220",
      "volume": "9",
      "year": "2010"
    }
  ],
  "reference-count": 45,
  "references-count": 45,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-012-9539-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome"
  ],
  "type": "journal-article",
  "volume": "11"
}